Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,155
Out of 4,829 analysts
46
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $9.54 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $56.75 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $310.67 | +3.00% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $83.48 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $31.00 | +54.84% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $156.57 | - | 4 | Apr 16, 2019 | |
| HSDT Helius Medical Technologies | Downgrades: Neutral | n/a | $4.20 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $137.70 | -41.90% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $8.05 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $51.63 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $133.24 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.15 | - | 1 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $102.86 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $84.67 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $73.68 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.54
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $56.75
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $310.67
Upside: +3.00%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $83.48
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $31.00
Upside: +54.84%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $156.57
Upside: -
Helius Medical Technologies
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $4.20
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $137.70
Upside: -41.90%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $8.05
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $51.63
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $133.24
Upside: -
Dec 13, 2017
Downgrades: Neutral
Price Target: n/a
Current: $0.15
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $102.86
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $84.67
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $73.68
Upside: -